Cargando…
Fetal Membranes Contribute to Drug Transport across the Feto-Maternal Interface Utilizing the Breast Cancer Resistance Protein (BCRP)
During pregnancy, the placenta is established as a primary organ for drug transport at the maternal-fetal interface. The fetal membranes (FM) also form an interface with maternal tissues; however, their role in drug transport has not been previously investigated. Knowledge of drug transport across t...
Autores principales: | Kammala, Ananthkumar, Benson, Meagan, Ganguly, Esha, Radnaa, Enkhtuya, Kechichian, Talar, Richardson, Lauren, Menon, Ramkumar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879081/ https://www.ncbi.nlm.nih.gov/pubmed/35207454 http://dx.doi.org/10.3390/life12020166 |
Ejemplares similares
-
Sodium Hydrogen Exchanger Regulatory Factor-1 (NHERF1) Regulates Fetal Membrane Inflammation
por: Kammala, Ananth Kumar, et al.
Publicado: (2020) -
Testing of drugs using human feto-maternal interface organ-on-chips provide insights into pharmacokinetics and efficacy
por: Richardson, Lauren S., et al.
Publicado: (2022) -
Extracellular vesicles from maternal uterine cells exposed to risk factors cause fetal inflammatory response
por: Shepherd, Megan C., et al.
Publicado: (2021) -
Exosomes from Ureaplasma parvum-infected ectocervical epithelial cells promote feto-maternal interface inflammation but are insufficient to cause preterm delivery
por: Tantengco, Ourlad Alzeus G., et al.
Publicado: (2022) -
Fetal membrane at the feto-maternal interface: An underappreciated and understudied intrauterine tissue
por: Richardson, Lauren, et al.
Publicado: (2022)